Genzyme MS drug shines in head-to-head trial with Rebif | InPharm

Links shared publicly online about this topic.

  • 356
    total visits

Genzyme MS drug shines in head-to-head trial with Rebif | InPharm

inpharm.com

Genzyme--™s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial

View full resource at inpharm.com

Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Rebif, Genzyme

  • Share

Most Recently Shared on April 18, 2011 at 9:53 am By:

Pharmafocus Pharmafocus

Genzyme MS drug shines in head-to-head trial with Rebif http://goo.gl/fb/6yK45

1 year ago...

Advertisement